title: A gene expression signature for RSV: clinical implications and limitations.
abstract: Peter Openshaw discusses the challenges in advancing respiratory syncytial virus (RSV) treatments and the implications of a study by Mejias and colleagues using a newly identified gene signature for diagnosis and prediction of RSV severity. Please see later in the article for the Editors' Summary.
authors.affiliation: National Heart and Lung Institute, Imperial College, London, United Kingdom.
authors.forename: Peter J M
authors.initials: PJ
authors.lastname: Openshaw
mesh_terms: D006801:Humans; D012313:RNA / Q000097:blood; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology / Q000821:virology; D012136:Respiratory Syncytial Viruses; D012720:Severity of Illness Index; D059467:Transcriptome
chemical_list: D012313:RNA